duloxetine + fluoxetine + citalopram + paroxetine + sertraline
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Depression
Conditions
Depression
Trial Timeline
May 1, 2008 โ Mar 1, 2009
NCT ID
NCT00666757About duloxetine + fluoxetine + citalopram + paroxetine + sertraline
duloxetine + fluoxetine + citalopram + paroxetine + sertraline is a approved stage product being developed by Eli Lilly for Depression. The current trial status is completed. This product is registered under clinical trial identifier NCT00666757. Target conditions include Depression.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00666757 | Approved | Completed |
Competing Products
20 competing products in Depression
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Olanzapine and Fluoxetine combination (OFC) + Fluoxetine | Eli Lilly | Phase 3 | 77 |
| Duloxetine | Eli Lilly | Approved | 85 |
| FK949E | Astellas Pharma | Phase 3 | 77 |
| Quetiapine | Astellas Pharma | Pre-clinical | 23 |
| duloxetine + escitalopram + placebo | Eli Lilly | Phase 3 | 77 |
| duloxetine | Eli Lilly | Approved | 85 |
| Duloxetine Hydrochloride | Eli Lilly | Phase 3 | 77 |
| Duloxetine | Eli Lilly | Approved | 85 |
| Duloxetine | Eli Lilly | Approved | 85 |
| Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro) | Eli Lilly | Approved | 85 |
| Duloxetine + Placebo | Eli Lilly | Phase 3 | 77 |
| Duloxetine | Eli Lilly | Approved | 85 |
| Olanzapine + Placebo | Eli Lilly | Phase 3 | 77 |
| Olanzapine + Fluoxetine + Placebo | Eli Lilly | Phase 3 | 77 |
| duloxetine + duloxetine | Eli Lilly | Pre-clinical | 23 |
| olanzapine + ziprasidone | Eli Lilly | Approved | 85 |
| Olanzapine Fluoxetine Combination (OFC) + Placebo | Eli Lilly | Approved | 85 |
| Drug treatment with Cymbalta | Eli Lilly | Approved | 85 |
| Duloxetine | Eli Lilly | Approved | 85 |
| Duloxetine | Eli Lilly | Approved | 85 |